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EFEKTYWNOSC NAPRAWY USZKO-
OZEN OKSYDACYJNYCH W RAKU
PIERSI
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Rykata J., Zadrozny M.3, Drzewoski J.4,
Stasiak J.1
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20ddziat Chirurgii Onkologicznej Szpitala
im. M. Kopernika w todzi, ul. Paderewskiego 4,
93-509 t6dz; 3Zaktad Patomorfologii Klinicznej
Instytut Centrum Zdrowia Matki Polki,
ul. Rzgowska 281/289,93-338 t6dz;
4Zaktad Farmakologii Klinicznej
Uniwersytetu Medycznego w todzi,
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Cel pracy: Celem pracy byto zbadanie
efektywnosci naprawy indukowanych
uszkodzen oksydacyjnych w DNA kom6-
rek os6b chorych na raka piersi.
Materiat i metodyka: Materiatem do ba-
dan byly Iimfocyty krwi obwodowej. Grup~
badana stanowito 25 kobiet z rakiem pier-
si, kontrolnq 30 bez nowotworu, dobranych
pod wzgl~dem wieku. Uszkodzenia oksy-
dacyjne w DNA Iimfocyt6w indukowano
dziataniem nadtlenku wodoru, doksoru-
bicyny oraz chlorku niklu. Poziom uszko-
dzen oraz efektywnose ich naprawy bada-
no przy uzyciu alkalicznej wersji testu ko-
metkowego.
Wyniki: Dla wszystkich testowanych
uktad6w badawczych stwierdzono zna-
cznie obnizonq skutecznose naprawy
uszkodzen oksydacyjnych w grupie z ra-
kiem piersi, w por6wnaniu do pr6by kon-
trolnej.
Wnioski: Niska sprawnose uktad6w na-
prawy DNA moze bye jednym z mecha-
nizm6w odgrywajqcych istotnq rol~ zar6-
wno w procesie powstawania nowotwor6w
piersi, jak i w ich rozwoju.
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THE ASSOCIATION BETWEEN LIPID
PEROXIDATION OR ANTIOXIDANT
ACTIVITY IN SERUM AND THE
CLINICAL STAGING OF CERVICAL
AND UTERINE CARCINOMA
Mackowiak-Matejczyk S., J6zwik M.,
J6zwik M., Poznanski J.
Regional Oncologic Center, 15-027 Bialystok,
Ogrodowa 12, and Department of Gynecology,
Medical University of Bialystok,
15-276 Bialystok, Sktodowskiej-Curie 24 A
Processes of lipid peroxidation are well
known to be the background of carcino-
genesis. However, little is known about the
intensity of these processes, as well as of
antioxidant activity in cases of genital
cancer in women. The dynamics of
peroxidation and/or antioxidation may
correlate with the clinical stage of the
disease.
Aim: The aim of the present investi-
gation was to evaluate the possible
relationship of serum concentration of
malondialdehyde (MDA) and TRAP antio-
xidant activity with clinical staging of cer-
vical and uterine carcinoma.
Materials and Methods: The study
involved 108 patients admitted to the Re-
gional Oncologic Center, Bialystok, during
the years 1999-2000: 73 women with
histopathologically confirmed cervical
carcinoma and 35 women with histopa-
thologically confirmed uterine carcinoma.
Clinical staging of the disease was
performed according to the FIGO
classification. The reference group were
25 healthy women aged 25-40 years, with
no history of chronic and infectious
disease and with a normal pelvic exa"
mination. Peripheral venous blood was
sampled for biochemical analyses.
The concentration of MDA (determined by
the colorimetric reaction with thiobarbituric
acid) was considered to be a measure
of lipid peroxidation. Total (peroxyl)-
radical-trapping antioxidant parameter,
or TRAP, was determined using an oxygen
electrode and was expressed as the
number of moles of peroxyl radical formed
in standardized laboratory conditions,
captured by 1 L of serum.
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Results: Generally, in comparison to
values found in healthy subjects (MDA
= mol/L), both in women with cervical
/-!mol/L; TRAP = 598.88 ± 81.65 /-!4.36
± 0.82 mol/L) and in women/-!mol/L; TRAP
= 755.24 ± 248.99 /-!carcinoma (MDA
= 4.83 ± 1.40 mol/L; TRAP = 799.78
± 238.04/-!with uterine carcinoma (MDA
= 5.24 ± 1.54 mol/L), there were signify-
cantly increased concentrations of MDA
(P = 0.05 and/-! P = 0.0139, respectively)
and of TRAP antioxidant activity
(P = 0.0001 and P = 0.0002, respectively).
No relationship was found between clinical
staging and MDA concentration, neither
in cervical nor uterine carcinoma. In con-
trast, TRAP antioxidant activity increased
significantly with clinical staging of cervical
carcinoma from FIGO 1° to IW(there were
no FIGO IVo patients), and with clinical
staging of uterine carcinoma from FIGO 1°
to W to IVO. In FIGO IW, there were only
2 uterine carcinoma patients, a fact ma-
king the data interpretation statistically
inadequate.
Conclusions: Soth in women with
cervical carcinoma and uterine carcinoma,
there are increased serum levels of a
marker of lipid peroxidation (MDA) and of
TRAP antioxidant activity. Clinical staging
of cervical and uterine carcinoma does not
affect the serum concentration of MDA.
However, TRAP antioxidant activity shows
an increase along with the clinical
progression of the carcinoma. We think
that the high TRAP antioxidant activity
found in cases of the studied carcinomas
may testify to the long-term preservation of
mechanisms defending the macroorga-
nism from the sequelae of peroxidation.
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SYNCHRONOUS AND METACHRO-
NOUS BILATERAL BREAST CAN-
CER - A COMPARISON OF CLINI-
CAL, HISTOPATHOLOGICAL
FEATURES OF THE FIRST AND SE-
COND PRIMARY BREAST CANCER
AND BRCA 1 AND 2 MUTATIONS
Nowicka E., Rogozinska J.,
Grzybowska E., Behrendt K.,
Mucha-Matecka A., Tarnawski R.
Center of Oncology, MCS Memorial Institute,
Gliwice
Purpose: to evaluate the clinical,
histopathological features of the first and
second primary breast cancer in patients
with bilateral breast cancer and to
determine the contribution of SRCA 1 and
2 mutations in SSC.
Material and methods: 131 patients
treated at Institute of Oncology MCS
Memorial in Gliwice between 1969-2002
developed bilateral breast cancer/SSC/.
There were 39 /29,7 %/synchronous and
92 /70,3%/ metachronous SSC. SRCA 1
and 2 mutations analysis was performed in
92 patients.
Results: Mean age of diagnosis of
cancer in SSSC and MSSC group was 52
and 46 /p=O, 002/.The proportion of early
stage tumors was significantly higher in
opposite side tumors compared to the first
primary tumor in both groups /p<O,OOOll.
The mean tumor diameter of first primary
and opposite breast tumors were 3,6 and
2,4 cm/p<0,00001/. A number of positive
correlations existed between tumors in
both breast in SSSC and MSSC-the
presence of ductal histology /p=0,002/, the
ER and PR status in SSSC /p<0,05/.
SRCA 1 and 2 mutations were recognized
in 27 % patients. All but two mutations
were detected in MSSC /p =0,006/.
Median follow-up from the diagnosis
of primary and SSC was 9,34 and 3,78
years. Five year DFS for SSSC and MSBC
were 67 and 93% respectively; MFS were
76 and 97%, RFS were 77 and 95%/ p<O,
05/. If the same analysis was performed
since the date of the second breast tumor
DFS, MFS and RFS did not reach
statistical significance in both groups.
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